Markers of increased risk for failure of adjuvant therapies.

Hayes DF. Markers of increased risk for failure of adjuvant therapies. Breast. 2003 Dec; 12(6):543-9.

View in: PubMed

Antineoplastic Agents, Hormonal
Antineoplastic Combined Chemotherapy Protocols
Biomarkers, Tumor
Breast Neoplasms
Chemotherapy, Adjuvant
Enzyme-Linked Immunosorbent Assay
Female
Humans
Predictive Value of Tests
Prognosis
Receptor, ErbB-2
Risk Assessment
Survival Analysis
Treatment Failure

Daniel Hayes

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement